Arq 과거 순이익 실적
과거 기준 점검 0/6
Arq은 연평균 47.1%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 연평균 4.6%의 비율로 감소했습니다. 매출은 연평균 9.5%의 비율로 증가했습니다.
핵심 정보
47.14%
순이익 성장률
24.43%
주당순이익(EPS) 성장률
| Chemicals 산업 성장률 | 12.93% |
| 매출 성장률 | 9.51% |
| 자기자본이익률 | -31.97% |
| 순이익률 | -43.93% |
| 다음 순이익 업데이트 | 10 Aug 2026 |
최근 과거 실적 업데이트
Recent updates
내러티브 업데이트 • Jul 23
ARQ: Index Removal And Higher Margins Will Support Future Repricing
Analysts have raised their price target on Arq by $1, reflecting updated assumptions that indicate lower revenue growth alongside higher profit margins and a reduced future P/E multiple. Together, these factors support a revised fair value estimate of $3.00 per share.
내러티브 업데이트 • Jul 09
ARQ: Index Removal And New CFO Appointment Will Reshape Future Prospects
Analysts have revised their outlook on Arq, with the consensus price target decreasing from $12.00 to $6.00. This update reflects new assumptions regarding fair value, discount rate, revenue growth, profit margin, and future P/E, as well as recent Street research, including the latest Canaccord price target change.
내러티브 업데이트 • Jun 25
ARQ: Future Upside Will Rely On Executing 2026 Earnings Guidance
Analysts raised their price target on Arq by $1 to $3.88, citing updated assumptions around discount rates, margins, and future P/E expectations. What’s in the News for Arq Arq reaffirmed earnings guidance for fiscal 2026, maintaining projected revenue in the range of US$120 million to US$125 million.내러티브 업데이트 • Jun 05
ARQ: Future Upside Will Depend On Core PAC Profitability As GAC Ramp Slips
Arq's analyst price target has been adjusted by $1 as analysts factor in updated expectations for profitable growth in the core PAC business, alongside revised assumptions for GAC utilization timing and related cost and revenue impacts. Analyst Commentary Bullish Takeaways Bullish analysts highlight the focus on profitable growth in the core PAC business as a key support for their valuation work, even as assumptions for other segments are adjusted.내러티브 업데이트 • Apr 23
ARQ: Future Upside Will Rely On Core Business As GAC Ramp Slows
Analysts have reduced their price target on Arq by $1.00 to $3.63, citing lower fair value assumptions, slightly higher discount rates, and tempered expectations for revenue growth and profit margins. They are reassessing the timing and profitability of the GAC ramp while focusing more on the core PAC business.내러티브 업데이트 • Apr 08
ARQ: Future Upside Will Depend On Core Business As GAC Timeline Resets
Analysts have reduced Arq's implied upside, with the consolidated price target easing to about $5 after recent cuts from $7.50 and $8. This largely reflects longer timelines and execution issues around the Granular Activated Carbon expansion and leadership changes, even as analysts still highlight a focus on profitable growth in the core PAC business.내러티브 업데이트 • Mar 25
ARQ: Future Upside Will Rely On Core Business While GAC Delays Resolve
Analysts have trimmed Arq's price target from $8.63 to $4.63 as they account for delays in the Granular Activated Carbon ramp up, leadership turnover, and a sharper focus on profitable growth in the core PAC business. Analyst Commentary Recent Street commentary reflects a mixed view on Arq, with targets reduced but overall constructive opinions on the risk and reward tradeoff after the stock reaction to recent updates.Seeking Alpha • Mar 11
Arq: Granular Activated Carbon Expansion Turns Into Disaster
Summary Activated carbon products supplier Arq reported mixed fourth-quarter results with a small top-line beat more than offset by weaker-than-expected profitability. ARQ management blamed ramp-up costs for the company's Granular Activated Carbon ("GAC") operations which have turned from a long-standing headache into a full-blown disaster. A combination of feedstock issues and design flaws has resulted in delays and cost overruns. As a result, management has halted GAC production in order to conduct a comprehensive review. Total investment required for a new off-gas train and addressing other issues might be north of $30 million with another equity raise looking like the only viable option. With the higher-margin GAC opportunity in limbo, I am reducing my price target from $4.20 to $2.00 while keeping my "Hold" rating on the stock. Read the full article on Seeking Alpha내러티브 업데이트 • Mar 09
ARQ: Refined Discount Rate And P/E Assumptions Will Support Future Upside Reassessment
Narrative update on Arq Analysts reduced their Arq price target by $0.50, citing updated assumptions around the discount rate and future P/E, while keeping fair value estimates broadly unchanged. Analyst Commentary Recent commentary around the updated Arq price target focuses on how small changes in key assumptions can shift upside and downside scenarios without materially changing the core story.내러티브 업데이트 • Feb 23
ARQ: Higher Discount Rate Will Ultimately Set Up Cleaner Upside Reassessment
Analysts have reduced their price target on Arq by $0.50 to reflect updated views on discount rate assumptions and minor adjustments to forward P/E expectations. Analyst Commentary Recent Street research indicates that analysts have adjusted their views on Arq primarily around the discount rate they apply and updated forward P/E assumptions.내러티브 업데이트 • Feb 08
ARQ: Extended Production Challenges Will Ultimately Support Higher Utilization Upside
Narrative Update on Arq Analysts have trimmed their Arq price targets by $0.50 to $1.00, generally pointing to a longer than expected timeline to resolve Granular Activated Carbon production issues and the resulting pushout of utilization and revenue expectations into the later years of their models. Analyst Commentary Recent research notes focus on how the extended Granular Activated Carbon, or GAC, production issues influence Arq's valuation, growth outlook, and execution risk.내러티브 업데이트 • Jan 23
ARQ: Extended GAC Timeline Will Ultimately Support Higher Utilization Upside
Narrative Update on Arq Analysts have trimmed their price target on Arq by about $0.13, citing a slower ramp in Granular Activated Carbon utilization and delayed capacity additions. This feeds through to slightly lower modeled fair value and P/E assumptions, despite somewhat higher forecast profit margins.내러티브 업데이트 • Jan 09
ARQ: Extended Production Timeline Will Ultimately Support Higher Utilization Upside
Narrative update on Arq Analysts have trimmed their price target on Arq to US$8 from US$9, citing expectations that issues with the new Granular Activated Carbon production line could persist into mid 2026 and slow the ramp to higher utilization and future revenue contributions. Analyst Commentary Recent commentary around Arq focuses on how the extended Granular Activated Carbon production ramp could affect the company’s timeline for scaling and its valuation framework.내러티브 업데이트 • Dec 21
ARQ: Future High Utilization Will Support Upside Despite Extended Production Delays
Analysts have trimmed their price target on Arq to $8.00 from $9.00, citing extended operational challenges and a slower than previously expected ramp in Granular Activated Carbon production, which has pushed out revenue growth and margin assumptions. Analyst Commentary Bullish analysts highlight that despite the reduced price target, the valuation still reflects confidence in Arq's long term growth potential, supported by expectations for eventual stabilization and high utilization of its Granular Activated Carbon operations.분석 기사 • Dec 13
We Think Arq (NASDAQ:ARQ) Has A Fair Chunk Of Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...내러티브 업데이트 • Dec 07
ARQ: Future Utilization Ramp Will Drive Upside Despite Delayed Expansion
Analysts have trimmed their price target on Arq by $1 to $8, citing a slower ramp to peak utilization and delayed expansion of its Granular Activated Carbon production as reasons for more conservative revenue and margin expectations in coming years. Analyst Commentary Recent Street research reflects a more tempered outlook on Arq, with valuation adjustments primarily driven by operational timing rather than a fundamental shift in the long-term thesis.내러티브 업데이트 • Nov 23
ARQ: Future Profitability Will Drive Share Price Upside Potential
Narrative Update on Arq Price Target Analysts have revised Arq’s fair value estimate downward from $11.13 to $9.38 per share, citing recent adjustments to growth and profitability assumptions. Valuation Changes Fair Value Estimate has decreased from $11.13 to $9.38 per share, reflecting a noticeable downward revision.분석 기사 • Aug 22
Revenues Tell The Story For Arq, Inc. (NASDAQ:ARQ) As Its Stock Soars 28%
Arq, Inc. ( NASDAQ:ARQ ) shares have continued their recent momentum with a 28% gain in the last month alone...내러티브 업데이트 • Aug 11
New GAC Line And RNG Expansion Will Fuel Demand
Arq’s consensus analyst price target increased to $9.88, primarily reflecting a higher future P/E multiple, which suggests improved growth or profitability expectations. What's in the News Arq, Inc.분석 기사 • Aug 07
These 4 Measures Indicate That Arq (NASDAQ:ARQ) Is Using Debt Extensively
NasdaqGM:ARQ 1 Year Share Price vs Fair Value Explore Arq's Fair Values from the Community and select yours Some say...새로운 내러티브 • May 17
Optimizing PAC Business And Launching GAC Will Secure Future Success
Strategic diversification into premium markets and life-of-asset contracts strengthen revenue growth and margin expansion, affirming Arq's market position.분석 기사 • Apr 09
Slammed 29% Arq, Inc. (NASDAQ:ARQ) Screens Well Here But There Might Be A Catch
To the annoyance of some shareholders, Arq, Inc. ( NASDAQ:ARQ ) shares are down a considerable 29% in the last month...분석 기사 • Mar 28
Does Arq (NASDAQ:ARQ) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Seeking Alpha • Mar 07
Arq: Granular Activated Carbon Expansion Project Remains A Headache - Hold
Summary Despite some operational headwinds, activated carbon products producer Arq, Inc. reported solid fourth-quarter results with decent gross margins and strong operating cash flow. However, the company's granular activated carbon (“GAC”) expansion project continued to experience substantial cost overruns and delays. Much higher than initially expected capex requirements have negatively impacted the company's liquidity. In addition, ramp-up delays are likely to result in margin pressures this year. At this point, the GAC business remains a black box for investors and given the slower ramp-up, market participants will continue to struggle with assessing potential returns on investment. Should Arq finally start to execute on its promises, there could be a considerable upside for the shares. However, should management continue to overpromise and underdeliver, the stock is likely to remain in the penalty box for now. Read the full article on Seeking Alpha분석 기사 • Nov 22
Arq, Inc.'s (NASDAQ:ARQ) 30% Jump Shows Its Popularity With Investors
Arq, Inc. ( NASDAQ:ARQ ) shares have had a really impressive month, gaining 30% after a shaky period beforehand. The...Seeking Alpha • Sep 20
Arq: Surprise Equity Offering Raises Questions (Rating Downgrade)
Summary After the close of Thursday's regular session, activated carbon products producer Arq, Inc. surprised market participants with a proposed equity offering. The offering comes just weeks after management advertised a near-term refinancing and material upsizing of the company's existing term loan facility. In the offering prospectus, the company disclosed the recent termination of the construction contract for its granular activated carbon ("GAC") manufacturing plant. Arq's stock is likely to remain in the penalty box until the company has proven its ability to ramp up GAC deliveries in time and on budget. Given persistent lack of execution and limited visibility regarding the financial impact of the new GAC business, I am downgrading the company's shares from "Hold" to "Sell". Read the full article on Seeking AlphaSeeking Alpha • Aug 20
Whether Or Not Trump Wins In November, Arq Is A $10 Stock
Summary ARQ shares have experienced a 37.7% drawdown from their 52-week-high to August 5th, driven by fears of potential changes in EPA regulations and a Trump win. ARQ competes in an oligopoly market and stands to benefit from increased demand for granular activated carbon well beyond Municipal Water. The GAC market is undersupplied. ARQ could have upwards of $25 million to $30 million of FY 2025 Adj. EBITDA power and has a lot of future EBITDA power, as its Red River plant can expand. Read the full article on Seeking AlphaSeeking Alpha • May 30
4 Reasons To Buy Arq Stock
Summary Arq, Inc. which specializes in the manufacture of environmental solutions has already generated impressive returns of 137% this year, outperforming the market. The company's granular activated carbon (GAC) portfolio is expected to benefit from new drinking water regulations and a potential supply deficit. Arq's gross margin progress is sustainable, driven by pricing effects with its PAC business, and the potential price-elastic nature of its GAC portfolio. ARQ offers solid topline growth outlook at a compelling EV/sales of just 1.5x. We appreciate the bullish developments on the charts, backed by growing institutional support, and the prospect for further rotational interest from investors focused on the environmental universe. Read the full article on Seeking Alpha분석 기사 • Apr 11
Does Arq (NASDAQ:ARQ) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Seeking Alpha • Mar 18
Arq, Inc.: A Pot Of Gold At The End Of The Rainbow
Summary Arq, previously known as Advanced Emissions Solutions, reported strong Q4 FY2023 earnings. This marks back-to-back positive Adj. EBITDA quarters. The company's March 13, 2024 conference call was super positive, and (arguably) very few people are paying attention. Last week, ARQ shares finished the week up 68% and have the potential for further growth. This article discusses why. Read the full article on Seeking Alpha매출 및 비용 세부 내역
매출 및 비용 세부 내역
Arq가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 31 Mar 26 | 122 | -54 | 29 | 7 |
| 31 Dec 25 | 120 | -53 | 28 | 7 |
| 30 Sep 25 | 118 | -4 | 27 | 7 |
| 30 Jun 25 | 118 | -2 | 30 | 5 |
| 31 Mar 25 | 114 | -1 | 31 | 3 |
| 31 Dec 24 | 109 | -5 | 32 | 4 |
| 30 Sep 24 | 110 | 0 | 33 | 5 |
| 30 Jun 24 | 105 | -4 | 36 | 4 |
| 31 Mar 24 | 100 | -8 | 36 | 4 |
| 31 Dec 23 | 99 | -12 | 36 | 3 |
| 30 Sep 23 | 94 | -19 | 38 | 2 |
| 30 Jun 23 | 93 | -19 | 34 | 2 |
| 31 Mar 23 | 97 | -14 | 32 | 1 |
| 31 Dec 22 | 103 | -9 | 32 | 0 |
| 30 Sep 22 | 80 | -102 | 26 | 1 |
| 31 Dec 21 | 0 | -116 | 16 | 4 |
양질의 수익: ARQ 은(는) 현재 수익성이 없습니다.
이익 마진 증가: ARQ는 현재 수익성이 없습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: ARQ는 수익성이 없지만 지난 5년 동안 연평균 47.1%의 속도로 손실을 줄였습니다.
성장 가속화: 현재 수익성이 없어 지난 1년간 ARQ의 수익 성장률을 5년 평균과 비교할 수 없습니다.
수익 대 산업: ARQ은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(-0.9%)와 비교하기 어렵습니다.
자기자본이익률
높은 ROE: ARQ는 현재 수익성이 없으므로 자본 수익률이 음수(-31.97%)입니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/07/31 17:19 |
| 종가 | 2026/07/31 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Arq, Inc.는 6명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| George Gianarikas | Canaccord Genuity |
| Aaron Spychalla | Craig-Hallum Capital Group LLC |
| Lars Christensen | Fearnley Securities |